· 6/27/2014
Yanise Germain v. Teva Pharmaceuticals, USA, Inc
Citations
- 756 F.3d 917
- 2014 WL 2959271
- 2014 U.S. App. LEXIS 12111
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- noting that under the Erie Doctrine, federal courts sitting in diversity are “bound by the rulings of the state supreme court”
- explaining that the FDA can only approve a drug when it determines the drug is “safe for use” as prescribed in the “proposed labeling thereof”
- finding that a plaintiff’s failure to update warnings claim to be “pure conjecture” because it was based solely on his beliefs
- holding negligence claims preempted under Buckman where “the conduct that [p]laintiffs allege gives rise to their statutory negligence claims is the [defendants’] violation of the FDCA.”
- explaining that parties forfeit issues that they do not properly raise on appeal
- explaining that parties forfeit issues that they do not properly raise on appeal
Source: CourtListener parenthetical corpus (CC0).
Judges: Suhrheinrich, Rogers, Sutton
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.